Upregulation of RUNX2 and Pim-1 was found to synergistically promote the development of T-cell lymphoma, suggesting the phosphorylation mediated by Pim-1 has a positive effect on RUNX2′s cancer-promoting function [108]. Here, RUNX2 is linked to T-cell non-Hodgkin lymphoma.